Arteriolar lesions in renal transplant biopsies: Prevalence, progression, and clinical significance

American Journal of Pathology

Volumn 180, Issue 5, 2012, Pages 1852-1862

  Brcker, Verena ^a   Schubert, Victoria ^a   Scheffner, Irina ^a   Schwarz, Anke ^a   Hiss, Marcus ^a   Becker, Jan Ulrich ^a   Scherer, Ralph ^a   Haller, Hermann ^a   Kreipe, Hans Heinrich ^a   Mengel, Michael ^b   Gwinner, Wilfried ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR;

ADULT; ARTERIOLAR LESION; ARTERY LESION; ARTICLE; CELL VACUOLE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT DYSFUNCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; REPRODUCIBILITY; SAMPLING ERROR; SMOOTH MUSCLE FIBER;

ADULT; AGE FACTORS; AGED; ARTERIOLES; BIOPSY; CYCLOSPORINE; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYALIN; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TACROLIMUS; TISSUE DONORS;

EID: 84860250725     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.01.038     Document Type: Article

References (47)

1. M.J. Mihatsch, G. Thiel, V. Basler, B. Ryffel, J. Landmann, J. von Overbeck, H.U. Zollinger Morphological patterns in cyclosporine-treated renal transplant recipients Transplant Proc 17 1985 101 116
2. M.J. Mihatsch, G. Thiel, B. Ryffel Histopathology of cyclosporine nephrotoxicity Transplant Proc 20 1988 759 771
3. E.H. Strøm, G. Thiel, M.J. Mihatsch Prevalence of cyclosporine-associated arteriolopathy in renal transplant biopsies from 1981 to 1992 Transplant Proc 26 1994 2585 2587
4. D.H. Taube, G.H. Neild, D.G. Williams, J.S. Cameron, B. Hartley, C.S. Ogg, C.J. Rudge, K.I. Welsh Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients Lancet 2 1985 171 174
5. M.E. Falkenhain, F.G. Cosio, D.D. Sedmak Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine Transplantation 62 1996 364 370
6. H.D. Humes, T. Coffman, H. Halderman, M. Mihatsch, M. Henry, G.A. Porter Cyclosporine nephrotoxicity: a workshop to discuss mechanisms, diagnosis, and treatment Transplant Proc 20 1988 833 840
7. T.T. Antonovych, S.G. Sabnis, H.A. Austin, A.G. Palestine, J.E. Balow, R.B. Nussenblatt, G.B. Helfrich, M.L. Foegh, M.R. Alijani Cyclosporine A-induced arteriolopathy Transplant Proc 20 1988 951 958
8. N. Marcussen, T.S. Olsen, H. Benediktsson, L. Racusen, K. Solez Reproducibility of the Banff classification of renal allograft pathology: inter- and intraobserver variation Transplantation 60 1995 1083 1089
9. K. Solez, R.A. Axelsen, H. Benediktsson, J.F. Burdick, A.H. Cohen, R.B. Colvin, B.P. Croker, D. Droz, M.S. Dunnill, P.F. Halloran International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology Kidney Int 44 1993 411 422
10. B. Sis, F. Dadras, F. Khoshjou, S. Cockfield, M.J. Mihatsch, K. Solez Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients Am J Transplant 6 2006 1444 1450
11. K. Solez, R.B. Colvin, L.C. Racusen, M. Haas, B. Sis, M. Mengel, P.F. Halloran, W. Baldwin, G. Banfi, A.B. Collins, F. Cosio, D.S.R. David, C. Drachenberg, G. Einecke, A.B. Fogo, I.W. Gibson, D. Glotz, S.S. Iskandar, E. Kraus, E. Lerut, R.B. Mannon, M. Mihatsch, B.J. Nankivell, V. Nickeleit, J.C. Papadimitriou, P. Randhawa, H. Regele, K. Renaudin, I. Roberts, D. Seron, R.N. Smith, M. Valente Banff 07 classification of renal allograft pathology: updates and future directions Am J Transplant 8 2008 753 760
12. L.C. Racusen, K. Solez, R.B. Colvin, S.M. Bonsib, M.C. Castro, T. Cavallo, B.P. Croker, A.J. Demetris, C.B. Drachenberg, A.B. Fogo, P. Furness, L.W. Gaber, I.W. Gibson, D. Glotz, J.C. Goldberg, J. Grande, P.F. Halloran, H.E. Hansen, B. Hartley, P.J. Hayry, C.M. Hill, E.O. Hoffman, L.G. Hunsicker, A.S. Lindblad, Y. Yamaguchi The Banff 97 working classification of renal allograft pathology Kidney Int 55 1999 713 723
13. A. Schwarz, M. Mengel, W. Gwinner, J. Radermacher, M. Hiss, H. Kreipe, H. Haller Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study Kidney Int 67 2005 341 348
14. D.W. Cockcroft, M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
15. B.J. Nankivell, R.J. Borrows, C.L.-S. Fung, P.J. O'Connell, R.D.M. Allen, J.R. Chapman The natural history of chronic allograft nephropathy N Engl J Med 349 2003 2326 2333
16. B.J. Nankivell, R.J. Borrows, C.L.S. Fung, P.J. O'Connell, J.R. Chapman, R.D.M. Allen Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology Transplantation 78 2004 557 565
17. B. Sis, G. Einecke, J. Chang, L.G. Hidalgo, M. Mengel, B. Kaplan, P.F. Halloran Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring Am J Transplant 10 2010 421 430
18. M.D. Stegall, W.D. Park, T.S. Larson, J.M. Gloor, L.D. Cornell, S. Sethi, P.G. Dean, M. Prieto, H. Am, S. Textor, T. Schwab, F.G. Cosio The histology of solitary renal allografts at 1 and 5 years after transplantation Am J Transplant 11 2011 698 707
19. R. Snanoudj, V. Royal, C. Elie, M. Rabant, C. Girardin, E. Morelon, H. Kreis, J-.C. Fournet, L-.H. Nol, C. Legendre Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy Am J Transplant 11 2011 2635 2646
20. S. Sund, A.V. Reisaeter, P. Fauchald, O. Bentdal, K.S. Hall, T. Hovig Living donor kidney transplants: a biopsy study 1 year after transplantation, compared with baseline changes and correlation to kidney function at 1 and 3 years Nephrol Dial Transplant 14 1999 2445 2454
21. M.J. Mihatsch, T. Antonovych, S.O. Bohman, R. Habib, U. Helmchen, L.H. Noel, S. Olsen, R.K. Sibley, E. Kemény, G. Feutren Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies Clin Nephrol 41 1994 23 32
22. K. Morozumi, G. Thiel, F.W. Albert, G. Banfi, F. Gudat, M.J. Mihatsch Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts Clin Nephrol 38 1992 1 8
23. N. Franceschini, C.E. Alpers, W.M. Bennett, T.F. Andoh Cyclosporine arteriolopathy: effects of drug withdrawal Am J Kidney Dis 32 1998 247 253
24. C. Sommerer, O. Hergesell, A.-M. Nahm, V. Schwenger, R. Waldherr, K. Andrassy, M. Zeier Cyclosporin A toxicity of the renal allograft: a late complication and potentially reversible Nephron 92 2002 339 345
25. B.S. Collins, C.L. Davis, C.L. Marsh, J.P. McVicar, J.D. Perkins, C.E. Alpers Reversible cyclosporine arteriolopathy Transplantation 54 1992 732 734
26. B.J. Nankivell, J.R. Chapman Chronic allograft nephropathy: current concepts and future directions Transplantation 81 2006 643 654
27. J.R. Chapman Longitudinal analysis of chronic allograft nephropathy: clinicopathologic correlations Kidney Int Suppl 2005 S108 S112
28. Z.M. El-Zoghby, M.D. Stegall, D.J. Lager, W.K. Kremers, H. Am, J.M. Gloor, F.G. Cosio Identifying specific causes of kidney allograft loss Am J Transplant 9 2009 527 535
29. A.J. Matas, R. Leduc, D. Rush, J.M. Cecka, J. Connett, A. Fieberg, P. Halloran, L. Hunsicker, F. Cosio, J. Grande, R. Mannon, S. Gourishankar, R. Gaston, B. Kasiske Histopathologic clusters differentiate subgroups within the nonspecific diagnoses of CAN or CR: preliminary data from the DeKAF study Am J Transplant 10 2010 315 323
30. M. Kubo, Y. Kiyohara, I. Kato, Y. Tanizaki, R. Katafuchi, H. Hirakata, S. Okuda, M. Tsuneyoshi, K. Sueishi, M. Fujishima, M. Iida Risk factors for renal glomerular and vascular changes in an autopsy-based population survey: the Hisayama study Kidney Int 63 2003 1508 1515
31. G.S. Hill Hypertensive nephrosclerosis Curr Opin Nephrol Hypertens 17 2008 266 270
32. R.E. Tracy Age trends of renal arteriolar hyalinization explored with the aid of serial sections Nephron Clin Pract 105 2007 c171 c177
33. G.S. Hill, D. Heudes, J. Bariéty Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation Kidney Int 63 2003 1027 1036
34. M.F. O'Rourke, J. Hashimoto Mechanical factors in arterial aging: a clinical perspective J Am Coll Cardiol 50 2007 1 13
35. F.G. Cosio, R.P. Pelletier, D.D. Sedmak, M.E. Falkenhain, M.L. Henry, E.A. Elkhammas, E.A. Davies, G.L. Bumgardner, R.M. Ferguson Pathologic classification of chronic allograft nephropathy: pathogenic and prognostic implications Transplantation 67 1999 690 696
36. M. Naesens, E. Lerut, H. de Jonge, B. Van Damme, Y. Vanrenterghem, D.R.J. Kuypers Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts J Am Soc Nephrol 20 2009 2468 2480
37. C. Metalidis, E. Lerut, M. Naesens, D.R.J. Kuypers Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity Transplantation 91 2011 1098 1102
38. D.R.J. Kuypers, M. Naesens, H. de Jonge, E. Lerut, K. Verbeke, Y. Vanrenterghem Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients Ther Drug Monit 32 2010 394 404
39. W.M. Bennett, A. DeMattos, M.M. Meyer, T. Andoh, J.M. Barry Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy Kidney Int 50 1996 1089 1100
40. A. Schwarz, H. Haller, R. Schmitt, M. Schiffer, C. Koenecke, C. Strassburg, F. Lehner, J. Gottlieb, C. Bara, J.U. Becker, V. Broecker Biopsy-diagnosed renal disease in patients after transplantation of other organs and tissues Am J Transplant 10 2010 2017 2025
41. J. Mason, E. Mller-Schweinitzer, M. Dupont, D. Casellas, M. Mihatsch, L. Moore, F. Kaskel Cyclosporine and the renin-angiotensin system Kidney Int Suppl 32 1991 S28 S32
42. E.H. Strøm, R. Epper, M.J. Mihatsch Ciclosporin-associated arteriolopathy: the renin producing vascular smooth muscle cells are more sensitive to ciclosporin toxicity Clin Nephrol 43 1995 226 231
43. B.A. Young, E.A. Burdmann, R.J. Johnson, T. Andoh, W.M. Bennett, W.G. Couser, C.E. Alpers Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy Kidney Int 48 1995 431 438
44. K. Horike, A. Takeda, Y. Yamaguchi, Y. Ogiyama, Y. Yamauchi, M. Murata, T. Kawaguchi, T. Suzuki, Y. Otsuka, D. Inaguma, N. Goto, Y. Watarai, K. Uchida, K. Morozumi Is arteriolar vacuolization a predictor of calcineurin inhibitor nephrotoxicity? Clin Transplant 25 Suppl 23 2011 23 27
45. J. Wiener, D. Spiro, R. Lattes The cellular pathology of experimental hypertension. II: Arteriolar hyalinosis and fibrinoid change Am J Pathol 47 1965 457 485
46. S. Sommers, A. Relman, R. Smithwick Histologic studies of kidney biopsy specimens from patients with hypertension Am J Pathol 34 1958 685 715
47. R. Hay, K. Tammi, B. Ryffel, M.J. Mihatsch Alterations in molecular structure of renal mitochondria associated with cyclosporine A treatment Clin Nephrol 25 Suppl 1 1986 S23 S26